semaglutide news october 20 2025 Canada approves generic from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Oral Semaglutide Approved to Reduce

#Pharma #Obesity #Diabetes #GLP1 #Semaglutide #IndiaHealthcare #Generics #Innovation To view or add a comment, sign in Saroglitazar Indias Innovation in Metabolic Healthcare India continues to make strides in pharmaceutical innovation, and Saroglitazar is a remarkable example of this progress

(The enzyme GGT can also catalyze a reaction with water or other oligopeptides as the substrate to generate glutamic acid or -glutamyloligopeptides and also release cysteinylglycine.) In the cell, -glutamyl cyclotransferase (step 2) releases the transported amino acid and cyclizes the glutamic acid to form 5-oxoproline (also called pyroglutamic acid)

Burn easily

The body responds by: slowing down how quickly the stomach empties acting on the area of the brain responsible for hunger improving blood sugar control These changes mean you feel fuller for longer, making it easier to eat fewer calories and to lose weight